United States RNAi Therapeutics for Rare Genetic D..

skapat en ny artikel

7 timmar

United States RNAi Therapeutics for Rare Genetic Disorders Market to Reach USD 0.70 Billion by 2034 as Precision Gene-Silencing Therapies Gain Momentum | #market research

United States RNAi Therapeutics for Rare Genetic Disorders Market to Reach USD 0.70 Billion by 2034 as Precision Gene-Si

According to a report by Intel Market Research, the United States RNAi Therapeutics for Rare Genetic Disorders Market was valued at USD 0.36 billion in 2025 and is projected to grow from USD 0.38 billion in 2026 to USD 0.70 billion by 2034, registering a CAGR of 8.9% during the forecast pe

Tycka om

Kommentar

Dela med sig

7 timmar

United States RNAi Therapeutics for Rare Genetic Disorders Market to Reach USD 0.70 Billion by 2034 as Precision Gene-Si

Språk